Stryker ROE 2010-2025 | SYK
Current and historical return on equity (ROE) values for Stryker (SYK) over the last 10 years. Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
| Stryker ROE - Return on Equity Historical Data | |||
|---|---|---|---|
| Date | TTM Net Income | Shareholder's Equity | Return on Equity |
| 2025-03-31 | $2.86B | $20.93B | 14.04% |
| 2024-12-31 | $2.99B | $20.63B | 15.02% |
| 2024-09-30 | $3.59B | $20.15B | 18.49% |
| 2024-06-30 | $3.45B | $19.76B | 18.28% |
| 2024-03-31 | $3.36B | $19.17B | 18.41% |
| 2023-12-31 | $3.17B | $18.59B | 17.89% |
| 2023-09-30 | $2.59B | $17.91B | 15.03% |
| 2023-06-30 | $2.71B | $17.36B | 16.09% |
| 2023-03-31 | $2.63B | $16.90B | 16.01% |
| 2022-12-31 | $2.36B | $16.62B | 14.78% |
| 2022-09-30 | $2.46B | $16.46B | 15.84% |
| 2022-06-30 | $2.08B | $15.67B | 13.91% |
| 2022-03-31 | $2.02B | $15.05B | 13.92% |
| 2021-12-31 | $1.99B | $14.88B | 14.15% |
| 2021-09-30 | $1.90B | $14.18B | 13.92% |
| 2021-06-30 | $2.08B | $13.82B | 15.61% |
| 2021-03-31 | $1.41B | $13.50B | 10.76% |
| 2020-12-31 | $1.60B | $13.08B | 12.31% |
| 2020-09-30 | $1.76B | $12.99B | 13.60% |
| 2020-06-30 | $1.60B | $12.75B | 12.56% |
| 2020-03-31 | $2.16B | $13.12B | 17.25% |
| 2019-12-31 | $2.08B | $12.81B | 17.09% |
| 2019-09-30 | $3.43B | $12.32B | 28.74% |
| 2019-06-30 | $3.55B | $11.94B | 31.40% |
| 2019-03-31 | $3.52B | $11.69B | 32.96% |
| 2018-12-31 | $3.55B | $11.73B | 35.29% |
| 2018-09-30 | $1.24B | $9.86B | 12.83% |
| 2018-06-30 | $1.08B | $9.46B | 11.05% |
| 2018-03-31 | $1.02B | $9.22B | 10.28% |
| 2017-12-31 | $1.02B | $9.98B | 10.16% |
| 2017-09-30 | $1.78B | $10.43B | 17.92% |
| 2017-06-30 | $1.70B | $10.04B | 17.61% |
| 2017-03-31 | $1.69B | $9.70B | 17.93% |
| 2016-12-31 | $1.65B | $9.55B | 17.91% |
| 2016-09-30 | $1.66B | $9.33B | 18.56% |
| 2016-06-30 | $1.61B | $9.10B | 18.39% |
| 2016-03-31 | $1.62B | $8.81B | 18.85% |
| 2015-12-31 | $1.44B | $8.51B | 17.02% |
| 2015-09-30 | $1.18B | $8.48B | 13.89% |
| 2015-06-30 | $0.93B | $8.51B | 10.96% |
| 2015-03-31 | $0.67B | $8.32B | 7.75% |
| 2014-12-31 | $0.52B | $8.60B | 5.84% |
| 2014-09-30 | $0.64B | $8.62B | 7.17% |
| 2014-06-30 | $0.69B | $9.00B | 7.67% |
| 2014-03-31 | $0.77B | $9.06B | 8.71% |
| 2013-12-31 | $1.01B | $9.05B | 11.55% |
| 2013-09-30 | $0.89B | $8.74B | 10.35% |
| 2013-06-30 | $1.14B | $8.60B | 13.41% |
| 2013-03-31 | $1.25B | $8.46B | 15.01% |
| 2012-12-31 | $1.30B | $8.60B | 15.77% |
| 2012-09-30 | $1.43B | $8.36B | 17.85% |
| 2012-06-30 | $1.40B | $7.95B | 17.98% |
| 2012-03-31 | $1.39B | $8.02B | 17.89% |
| 2011-12-31 | $1.35B | $7.68B | 17.66% |
| 2011-09-30 | $1.24B | $7.56B | 16.54% |
| 2011-06-30 | $1.25B | $7.78B | 16.82% |
| 2011-03-31 | $1.26B | $7.45B | 17.55% |
| 2010-12-31 | $1.27B | $7.17B | 18.25% |
| 2010-09-30 | $1.28B | $7.31B | 18.80% |
| 2010-06-30 | $1.18B | $6.75B | 17.78% |
| 2010-03-31 | $1.15B | $6.67B | 17.82% |
| 2009-12-31 | $1.11B | $6.60B | 17.91% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $149.710B | $22.595B |
| Stryker Corporation is a medical device company operating in the global orthopedic market. The company has three business segments: Orthopaedics, MedSurg and Neurotechnology & Spine. Orthopaedic?products include implants used in hip and knee joint replacements and trauma and extremities surgeries. MedSurg?products consists of surgical equipment and surgical navigation systems; endoscopic and communications systems; patient handling and emergency medical equipment and reprocessed and remanufactured medical devices. Neurotechnology & Spine division includes both neurosurgical and neurovascular devices. These includes products used for minimally invasive endovascular techniques; traditional brain and open skull base surgical procedures; orthobiologic and biosurgery products and minimally invasive products for the treatment of acute ischemic and hemorrhagic stroke. Spinal implant product offering includes cervical, thoracolumbar and interbody systems used in spinal injury, deformity and degenerative therapies. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $239.054B | 28.75 |
| Boston Scientific (BSX) | United States | $154.291B | 38.63 |
| EssilorLuxottica (ESLOY) | France | $128.407B | 0.00 |
| Medtronic (MDT) | Ireland | $110.260B | 15.63 |
| Lonza Group Ag (LZAGY) | Switzerland | $50.622B | 0.00 |
| Haleon (HLN) | United Kingdom | $47.216B | 26.92 |
| ResMed (RMD) | United States | $37.817B | 28.40 |
| Agilent Technologies (A) | United States | $33.696B | 21.97 |
| GE HealthCare Technologies (GEHC) | United States | $33.311B | 15.81 |
| Terumo (TRUMY) | Japan | $27.198B | 35.33 |
| Koninklijke Philips (PHG) | Netherlands | $23.033B | 16.16 |
| Insulet (PODD) | United States | $21.551B | 84.59 |
| Zimmer Biomet Holdings (ZBH) | United States | $18.358B | 11.79 |
| Baxter (BAX) | United States | $15.708B | 11.73 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $13.095B | 0.00 |
| Demant (WILYY) | Denmark | $9.110B | 0.00 |
| Sunny Optical Technology (SNPTF) | China | $8.561B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $6.558B | 22.82 |
| Lantheus Holdings (LNTH) | United States | $5.573B | 14.06 |
| Prestige Consumer Healthcare (PBH) | United States | $4.039B | 18.04 |
| Perrigo (PRGO) | Ireland | $3.660B | 9.28 |
| Haemonetics (HAE) | United States | $3.526B | 16.06 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $3.459B | 0.00 |
| Envista Holdings (NVST) | United States | $3.280B | 27.25 |
| ICU Medical (ICUI) | United States | $3.251B | 23.97 |
| GN Store Nord (GNNDY) | Denmark | $2.346B | 19.43 |
| LeMaitre Vascular (LMAT) | United States | $1.910B | 42.70 |
| QuidelOrtho (QDEL) | United States | $1.901B | 13.07 |
| AtriCure (ATRC) | United States | $1.598B | 0.00 |
| Acuren (TIC) | United States | $1.263B | 0.00 |
| AdaptHealth (AHCO) | United States | $1.216B | 12.34 |
| Green Thumb Industries (GTBIF) | United States | $1.111B | 25.00 |
| Neogen (NEOG) | United States | $1.057B | 13.53 |
| BioLife Solutions (BLFS) | United States | $1.015B | 0.00 |
| Phibro Animal Health (PAHC) | United States | $1.003B | 12.82 |
| Kestra Medical Technologies (KMTS) | United States | $0.908B | 0.00 |
| InMode (INMD) | Israel | $0.898B | 9.05 |
| CeriBell (CBLL) | United States | $0.698B | 0.00 |
| Owens & Minor (OMI) | United States | $0.607B | 5.04 |
| Evolus (EOLS) | United States | $0.587B | 0.00 |
| Maravai LifeSciences Holdings (MRVI) | United States | $0.578B | 0.00 |
| Curaleaf Holdings (CURLF) | Canada | $0.557B | 0.00 |
| Valneva SE (VALN) | France | $0.468B | 0.00 |
| Capricor Therapeutics (CAPR) | United States | $0.459B | 0.00 |
| Surmodics (SRDX) | United States | $0.413B | 0.00 |
| Tilray Brands (TLRY) | Canada | $0.396B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.335B | 12.32 |
| SNDL (SNDL) | Canada | $0.321B | 0.00 |
| SEMPERIT AG HLD (SEIGY) | Austria | $0.301B | 0.00 |
| Sanuwave Health (SNWV) | United States | $0.281B | 0.00 |
| Viemed Healthcare (VMD) | United States | $0.276B | 23.27 |
| Cerus (CERS) | United States | $0.252B | 0.00 |
| Cresco Labs (CRLBF) | United States | $0.250B | 0.00 |
| ZimVie (ZIMV) | United States | $0.250B | 11.34 |
| Sanara MedTech (SMTI) | United States | $0.249B | 0.00 |
| Quanterix (QTRX) | United States | $0.241B | 0.00 |
| Brainsway (BWAY) | Israel | $0.233B | 61.65 |
| Biote (BTMD) | United States | $0.227B | 6.37 |
| Canopy Growth (CGC) | Canada | $0.226B | 0.00 |
| Aurora Cannabis (ACB) | Canada | $0.220B | 65.33 |
| OraSure Technologies (OSUR) | United States | $0.215B | 0.00 |
| Omeros (OMER) | United States | $0.205B | 0.00 |
| TriSalus Life Sciences (TLSI) | United States | $0.197B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.181B | 14.71 |
| High Tide (HITI) | Canada | $0.178B | 0.00 |
| Organigram Global (OGI) | Canada | $0.177B | 0.00 |
| Verano Holdings (VRNOF) | United States | $0.175B | 0.00 |
| Exagen (XGN) | United States | $0.144B | 0.00 |
| Vireo Growth (VREOF) | United States | $0.138B | 0.00 |
| FitLife Brands (FTLF) | United States | $0.120B | 14.81 |
| Jin Medical (ZJYL) | China | $0.108B | 0.00 |
| Veru (VERU) | United States | $0.102B | 0.00 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.089B | 0.00 |
| Fonar (FONR) | United States | $0.088B | 11.32 |
| Quipt Home Medical (QIPT) | United States | $0.084B | 0.00 |
| MacroGenics (MGNX) | United States | $0.083B | 0.00 |
| TerrAscend (TSNDF) | Canada | $0.078B | 0.00 |
| Cytosorbents (CTSO) | United States | $0.075B | 0.00 |
| Zynex (ZYXI) | United States | $0.074B | 0.00 |
| Apyx Medical (APYX) | United States | $0.072B | 0.00 |
| InterCure (INCR) | Israel | $0.067B | 0.00 |
| Agape ATP (ATPC) | $0.063B | 0.00 | |
| Jushi Holdings (JUSHF) | United States | $0.061B | 0.00 |
| ImmuCell (ICCC) | United States | $0.055B | 0.00 |
| Nephros (NEPH) | United States | $0.045B | 59.98 |
| Modular Medical (MODD) | United States | $0.044B | 0.00 |
| United-Guardian (UG) | United States | $0.038B | 13.25 |
| Rockwell Medical (RMTI) | United States | $0.028B | 0.00 |
| Safety Shot (SHOT) | United States | $0.023B | 0.00 |
| Allurion Technologies (ALUR) | United States | $0.018B | 0.00 |
| INLIF (INLF) | $0.016B | 0.00 | |
| Flora Growth (FLGC) | United States | $0.015B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.014B | 0.00 |
| Meihua Medical Technologies (MHUA) | China | $0.014B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.014B | 0.00 |
| Senestech (SNES) | United States | $0.007B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.007B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.006B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.004B | 0.00 |
| Akanda (AKAN) | Canada | $0.002B | 0.00 |
| Sharps Technology (STSS) | United States | $0.000B | 0.00 |
| InVivo Therapeutics Holdings (NVIVQ) | United States | $0.000B | 0.00 |